-
Galliano pulls Met Gala exhibit after antisemitism backlash
-
Jury hears closing arguments in Tupac Shakur murder trial
-
Afghan people should 'not be abandoned': top Red Cross official
-
Pakistan sack coach, send seven players home after England defeats
-
Six defining moments of Lionel Messi's Argentina career
-
New storms threaten Grand Canyon flood search, 2 bodies recovered
-
Trump blasts US backlash against data centers
-
France takes aim at ultra-fast fashion with new levy
-
It 'hurts' says Messi of decision to retire from international football
-
Tribunal says India cannot withdraw from water treaty with Pakistan
-
Benzema ends brief stint with Al Hilal in Saudi league
-
John Galliano pulls US exhibition after antisemitism backlash
-
Djokovic's Grand Slam future uncertain after brutal US Open defeat
-
French Top 14 boss offers 'no guarantees' for first Club World Cup
-
Turkey says regional defence pact not against any country
-
Munoz reunites with Glasner after joining Forest from Palace
-
US vows to keep economic pressure on Iran as G20 finance talks begin
-
Liverpool sign Barcola from PSG for £124 million
-
Shein valued at $26.3 bn in Hong Kong market debut
-
Putin, Xi hold talks in Kyrgyzstan as regional summit begins
-
Crude prices rise above $90 per barrel on US-Iran strikes
-
ChatGPT becomes first AI chatbot to face tougher EU rules
-
Liverpool sign Barcola from PSG for reported £124 million
-
Man City sign Palmeiras winger Allan on five-year deal
-
Putin, Xi, Iran's Pezeshkian in Kyrgyzstan for summit
-
More flooding feared at Grand Canyon after storm leaves 15 missing
-
Fully Permitted Tanzanian Gold Project Clears Path to Construction as Financing, EPCM Fall in Place (LVGLF)
-
RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
-
EdWealth Announces MoneyBench Benchmark Comparing AI Money Answers From Ed, ChatGPT and Gemini
-
MEXC Data: BTC Breaks $80,000, Major-Asset Spot Trading Volume Surges 300%
-
Root says new balls behind batsmen's struggles in England
-
G20 finance talks open as US seeks to ramp up pressure on Iran
-
Swollen rivers, washed-out roads hamper Nepal rescue effort
-
Solving Agent Sprawl: The Case for Enterprise Orchestration
-
In France's north, winegrowers bet on a warmer future
-
Springboks switch Kolbe to full-back for third All Blacks Test
-
Deadly virus stalks South Africa's sardines
-
Malaysia's Sarawak eyes cloud seeding as haze worsens
-
South Korea women's football body probes 'period' insult
-
World leaders need to see rising oceans in Pacific: UN official
-
Transitional Fashion Essentials for Autumn: Key Pieces from M&S and Joe Browns
-
Xiaomi Pad 9 Pro Leak Suggests 12.5-Inch Display and Massive Battery
-
China's Xi and Iran's Pezeshkian in Kyrgyzstan, Putin expected
-
UK Homeowners Advised to Use Peppermint Tea Bags to Deter Spiders
-
Rescuers hunt for missing after deadly N.Cyprus ferry accident
-
Nepal toll surges as rescuers struggle through 'unimaginable' disaster
-
Ethiopia's Abiy could consolidate power as 'executive president'
-
Mauled Australian swimmer recalls punching shark
-
Crude prices rise on US-Iran strikes, equities mixed after Warsh remarks
-
Passengers stranded overnight by Kenya airport strike
FriskaAi and Dexcom Enter CGM Data Integration Agreement
ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into the FriskaAi platform. Under the agreement, data from Dexcom CGMs will be integrated with Friska Ai, the company's groundbreaking AI-powered healthcare platform supporting physicians and patients with actionable personalized care management programs.
FriskaAi is a physician-directed health and wellness platform that supports the management of diabetes and other chronic diseases by helping providers take an evidence-based approach to preventive care. The EHR-agnostic FriskaAi platform leverages advanced AI and mobile technology to generate personalized health insights and recommendations, empowering patients to take control of their health journey in partnership with their clinical team.
"Impacting more than 38 million Americans, diabetes has emerged as a major public health problem, and its effective management has become a foundational element of preventive medicine," says Shaji Nair, CEO of FriskaAi. "Dexcom's pioneering CGMs are vital tools not only for diabetes management but also for informing broader care decisions. FriskaAi is excited about the potential this integration with Dexcom presents to the physicians relying on our platform for chronic disease management and the patients seeking greater control over their health and wellness."
Dexcom CGMs use a small, wearable sensor to continuously measure and send glucose levels wirelessly to a smart device or receiver in real-time, without the need for fingerpricks. Dexcom CGMs also offer a suite of customizable alerts that can warn of high or low glucose levels and send predictive alerts to help users spend more time in range.
The FriskaAi mobile app securely integrates with Dexcom CGMs and other smart devices, as well as health apps, for analysis by the powerful HIPAA-compliant FriskaAi platform. That data, along with other clinical data and studies, is continuously monitored by sophisticated AI-powered algorithms that alert the patient when action is recommended and generate actionable reports for use by the clinician at the point of care to inform care decisions.
Aggregated health data is also analyzed within the FriskaAI platform to help physicians identify trends and risks within their patient populations, enabling more proactive and preventive care strategies.
About FriskaAi
FriskaAi is a powerful AI-enabled EHR-agnostic platform that helps physicians and other providers take an evidence-based approach to preventive care. The physician-initiated platform leverages advanced AI- and mobile technology to provide patients with personalized health insights and recommendations, empowering them to take control of their health journey in partnership with their clinical team. This aggregated health data, including information from patients' glucometers, other smart devices, and health apps, is continuously analyzed by advanced evidence-based algorithms that alert the patient when action is needed and provide clinicians with actionable reports to inform care decisions. FriskaAi also supports population health strategies by analyzing aggregated health data to identify trends and risks within a defined patient population. For more information, visit www.friska.ai.
Media Contact:
Michele Nachum
NPC Creative Services
[email protected]
SOURCE: FriskaAi
View the original press release on ACCESS Newswire
N.Mitchell--AT